Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Sidley says it advises GSK on €3.5 billion notes issuance
Sidley announced that it had represented GSK on a €3.5 billion notes issuance by GSK Capital B.V., guaranteed by GSK plc. The firm said proceeds repaid acquisition-facility borrowings associated with Nuvalent and supported general corporate purposes, with David Howe and Omar Shafi leading its London team.
Key points
- Sidley said the issuance included €850 million in floating-rate notes due March 2028.Sidley Austin
- The firm reported €1 billion in 3.5% notes due 2030.Sidley Austin
- Sidley reported €850 million in 3.875% notes due 2034.Sidley Austin
- The firm said the remaining €800 million carried a 4.125% coupon and matured in 2037.Sidley Austin